Endoscopic Ultrasound-Guided Drainage of Intra-Abdominal Abscess after Gastric Perforation in a Patient Receiving Ramucirumab and Paclitaxel for Advanced Gastric Cancer

Gastrointestinal perforation is a serious adverse event that occurs in approximately 1% of patients receiving ramucirumab and paclitaxel. A 67-year-old man with unresectable advanced gastric cancer was admitted to our hospital and treated with ramucirumab and paclitaxel. Gastric perforation occurred...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandai, Koichiro, Shirakawa, Atsushi, Uno, Koji, Yasuda, Kenjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301121/
https://www.ncbi.nlm.nih.gov/pubmed/28203161
http://dx.doi.org/10.1159/000455226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301121/
https://www.ncbi.nlm.nih.gov/pubmed/28203161
http://dx.doi.org/10.1159/000455226

Ejemplares similares